drugset / Trial / NCT05580029

Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions

NCT05580029 ↗

Phase 0 Unknown 10 enrolled University of Southern California
NaSingle-groupOpen-labelTreatment

Summary

Assess the efficacy of fractional ablative CO2 therapy combined with topical steroids in HS patients with Hurley stage I or stage II disease. Hidradenitis suppurativa (HS) is a chronic, oftentimes debilitating inflammatory skin condition that presents with painful lesions in intertriginous areas of the body. The reported prevalence of HS in the U.S. is around 1-4%. Medical therapies, which typically consist of topical or systemic antibiotics, hormone- regulating drugs, and immunomodulators, are initially used to control the disease but HS can be recalcitrant to these modalities in the long-term. Optimizing management of mild-moderate HS is crucial to prevent disease progression and improve patients' quality of life.

Timeline

Start
2022-11-01
Primary completion
2023-01-20
Completion
2023-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background EMLA Unknown 2 g Topical